Morphological and molecular features of recurrent endometrioid ovarian cysts

In: Journal of obstetrics and women's diseases · 2022 · vol. 71(5) , pp. 29–39 · doi:10.17816/jowd111041 · W4313378587
article OA: closed CC0
Full text JSON View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-06

Recurrent endometrioid ovarian cysts exhibit increased expression of macrophages, TGF-β1, α-SMA, and CD34, indicating heightened inflammation, angiogenesis, and fibrogenesis compared to non-recurrent cases.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-06 · read from full text

This study evaluated morphological and immunohistochemical features of recurrent endometrioid ovarian cysts in reproductive-age patients using 196 surgical specimens: 23 from first operations with later relapse, 22 from repeat surgeries, and 151 from relapse-free disease, stained for CD68, TGF-β1, CD34, and α-smooth muscle actin. Compared with relapse-free cases, recurrent cysts showed significantly higher CD68 expression in cytogenic stroma and cyst capsule after the first and second operations, higher TGF-β1 area in the capsule after both operations, and α-smooth muscle actin increases in cytogenic stroma and capsule particularly after the second recurrent surgery. CD34 expression was also greater in recurrent endometriosis across both operation timepoints. The paper is limited by its reliance on tissue analyses from surgical material rather than functional outcomes and does not provide a direct mechanism beyond associations. This paper is centrally about endometriosis — specifically, recurrent endometrioid ovarian cysts and associated macrophage inflammation, angiogenesis, and fibrogenic marker changes in surgical specimens.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

BACKGROUND: One of the clinical course features of ovarian endometriosis is its recurrent nature, which leads to repeated operations and increased damage to the ovarian follicular apparatus. AIM: The aim of this study was to evaluate morphological and molecular features of recurrent endometrioid ovarian cysts in patients of reproductive age. MATERIALS AND METHODS: Morphological and immunohistochemical studies of the surgical material of 196 observations of endometrioid ovarian cysts were performed 23 observations of the first surgical intervention with further diagnosed relapse, 22 observations of repeated surgery and 151 observations of a relapse-free course of endometriosis. Monoclonal mouse antibodies to CD68, transforming growth factor -1, CD34, and -smooth muscle actin were used. RESULTS: CD68 (macrophage) expression was detected in lympho-macrophage infiltrates of the cytogenic stroma and endometrioid cyst capsule. Significantly greater values of the expression were obtained in recurrent endometrioid cysts in the surgical material of both the first (cytogenic stroma 31 [8; 53]%, capsule 23 [3; 42]%) and second operation (23 [12; 36] and 9 [5; 20]%, respectively) compared to the relapse-free course of the disease (8 [6; 9] and 2 [0; 4]%, respectively). The transforming growth factor -1 expression area in the endometrioid cyst capsule was significantly higher in the surgical material of both the first (22.8 [21.6; 24.8]%) and second operation (31.2 [30.5; 32.2]%) with recurrent endometriosis compared to cases with no relapse (12.7 [11.2; 13.9]%). But in the cytogenic stroma was it only detected in cases of repeated surgical endometrioid cyst treatment (18.7 [18.0; 19.7]%). The positive -smooth muscle actin expression area was higher in the surgical material of the second operation with recurrent endometriosis in both the cytogenic stroma (68.3 [66.3; 69.6]%) and endometrioma capsule (82.5 [80.5; 83.8]%). A large area of CD34 expression was also detected in the recurrent course of ovarian endometriosis in the surgical material of both the first (cytogenic stroma 34.8 [33.4; 35.8]%, capsule 52.6 [50.4; 55.0]%) and second operation (51.3 [49.0; 53.3] and 48.7 [46.7; 49.8]%, respectively). CONCLUSIONS: The recurrent course of ovarian endometriosis is characterized by more pronounced inflammation, angiogenesis, myofibroblast proliferation, and fibrogenesis, which indicates the importance of these pathological processes in the chronicity of the disease. Further study of the role of macrophages and the cascade of regenerative and reparative processes that they trigger is important for understanding the pathogenesis of endometriosis and searching for diagnostic markers of its recurrent course.
Full text 8,193 characters · extracted from oa-doi-fallback · 5 sections · click to expand

Abstract

BACKGROUND: One of the clinical course features of ovarian endometriosis is its recurrent nature, which leads to repeated operations and increased damage to the ovarian follicular apparatus. AIM: The aim of this study was to evaluate morphological and molecular features of recurrent endometrioid ovarian cysts in patients of reproductive age.

Materials and methods

Morphological and immunohistochemical studies of the surgical material of 196 observations of endometrioid ovarian cysts were performed — 23 observations of the first surgical intervention with further diagnosed relapse, 22 observations of repeated surgery and 151 observations of a relapse-free course of endometriosis. Monoclonal mouse antibodies to CD68, transforming growth factor β-1, CD34, and α-smooth muscle actin were used.

Results

CD68 (macrophage) expression was detected in lympho-macrophage infiltrates of the cytogenic stroma and endometrioid cyst capsule. Significantly greater values of the expression were obtained in recurrent endometrioid cysts in the surgical material of both the first (cytogenic stroma — 31 [8; 53]%, capsule — 23 [3; 42]%) and second operation (23 [12; 36] and 9 [5; 20]%, respectively) compared to the relapse-free course of the disease (8 [6; 9] and 2 [0; 4]%, respectively). The transforming growth factor β-1 expression area in the endometrioid cyst capsule was significantly higher in the surgical material of both the first (22.8 [21.6; 24.8]%) and second operation (31.2 [30.5; 32.2]%) with recurrent endometriosis compared to cases with no relapse (12.7 [11.2; 13.9]%). But in the cytogenic stroma was it only detected in cases of repeated surgical endometrioid cyst treatment (18.7 [18.0; 19.7]%). The positive α-smooth muscle actin expression area was higher in the surgical material of the second operation with recurrent endometriosis in both the cytogenic stroma (68.3 [66.3; 69.6]%) and endometrioma capsule (82.5 [80.5; 83.8]%). A large area of CD34 expression was also detected in the recurrent course of ovarian endometriosis in the surgical material of both the first (cytogenic stroma — 34.8 [33.4; 35.8]%, capsule — 52.6 [50.4; 55.0]%) and second operation (51.3 [49.0; 53.3] and 48.7 [46.7; 49.8]%, respectively).

Conclusions

The recurrent course of ovarian endometriosis is characterized by more pronounced inflammation, angiogenesis, myofibroblast proliferation, and fibrogenesis, which indicates the importance of these pathological processes in the chronicity of the disease. Further study of the role of macrophages and the cascade of regenerative and reparative processes that they trigger is important for understanding the pathogenesis of endometriosis and searching for diagnostic markers of its recurrent course. Full Text About the authors Nikol N. Petrovskaia North-Western State Medical University named after I.I. Mechnikov Author for correspondence. Email: [email protected] ORCID iD: 0000-0001-6849-5335 SPIN-code: 7769-1969 Scopus Author ID: 57838172500 Russian Federation, Saint Petersburg Victoria A. Pechenikova North-Western State Medical University named after I.I. Mechnikov Email: [email protected] ORCID iD: 0000-0001-5322-708X SPIN-code: 9603-5645 MD, Dr. Sci. (Med.), Professor Russian Federation, Saint PetersburgDarya M. Chashchina North-Western State Medical University named after I.I. Mechnikov Email: [email protected] ORCID iD: 0000-0002-5372-3515 SPIN-code: 1213-8079 Russian Federation, Saint Petersburg

References

- Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382(13):1244–1256. doi: 10.1056/NEJMra1810764 - Fassbender A, Overbergh L, Verdrengh E, et al. How can macroscopically normal peritoneum contribute to the pathogenesis of endometriosis? Fertil. steril. 2011;96(3):697−699. doi: 10.1016/j.fertnstert.2011.06.034 - Seo JW, Lee DY, Yoon BK, et al. The age-related recurrence of endometrioma after conservative surgery. Eur J Obstet Gynecol Reprod Biol. 2017;208:81−85. doi: 10.1016/j.ejogrb.2016.11.015 - Fedele L, Bianchi S, Zanconato G, et al. Tailoring radicality in demolitive surgery for deeply infiltrating endometriosis. Am J Obstet Gynecol. 2005;193(1):114–117. doi: 10.1016/j.ajog.2004.12.085 - Nirgianakis K, Ma L, McKinnon B, et al. Recurrence patterns after surgery in patients with different endometriosis subtypes: a long-term hospital-based cohort study. J Clin Med. 2020;9(2);496. doi: 10.3390/jcm9020496 - Moskalev AV, Rudoy AS, Apchel AV, et al. Osobennosti biologii transformirujushhego rostovogo faktora β i immunopatologija. Vestnik Rossijskoj voenno-medicinskoj akademii. 2016;2(54):206–216. (In Russ.) - Symons LK, Miller JE, Kay VR, et al. The immunopathophysiology of endometriosis. Trends in molecular medicine. 2018;24:748–762. doi: 10.1016/j.molmed.2018.07.004 - Shigesi N, Kvaskoff M, Kirtley S, et al. The association between endometriosis and autoimmune diseases: a systematic review and meta-analysis. Hum Reprod Update. 2019;25:486–503. doi: 10.1093/humupd/dmz014 - Mu F, Harris HR, Rich-Edwards JW, et al. A prospective study of inflammatory markers and risk of endometriosis. Am J Epidemiol. 2018;187(3):515–522. doi: 10.1093/aje/kwx272 - Capobianco A, Rovere-Querini P. Endometriosis, a disease of the macrophage. Front Immunol. 2013;4:9. doi: 10.3389/fimmu.2013.00009 - Goldmann O, von Köckritz-Blickwede M, Höltje C, et al. E. Transcriptome analysis of murine macrophages in response to infection with Streptococcus pyogenes reveals an unusual activation program. Infect Immun. 2007;75(8):4148–4157. doi: 10.1128/IAI.00181-07 - Martinez FO, Sica A, Mantovani A, et al. Macrophage activation and polarization. Front Biosci. 2008;13:453–461. doi: 10.2741/2692 - Bacci M, Capobianco A, Monno A, et al. Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Amn J Pathol. 2009;175(2):547–556. doi: 10.2353/ajpath.2009.081011 - Smith KA, Pearson CB, Hachey AM, et al. Alternative activation of macrophages in rhesus macaques (Macaca mulatta) with endometriosis. Comp Med. 2012;62(4):303–310. - Hu W, Li X, Zhang C, et al. Tumor-associated macrophages in cancers. Clin Transl Oncol. 2016;18(3):251–258. doi: 10.1007/s12094-015-1373-0 - Kuz’mina N.S. Novyye podkhody k preodoleniyu besplodiya u bol’nykh s endometriomami yaichnikov pri snizhenii ovarial’nogo rezerva [dissertation abstract]. Saint Petersburg; 2019. [cited 2022 Sept 15]. Available from: https://www.dissercat.com/content/novye-podkhody-k-preodoleniyu-besplodiya-u-bolnykh-s-endometriomami-yaichnikov-pri-snizhenii - Velikorodnaya YuI, Pocheptsov AYa. Dynamic changes in vimetin and smooth muscle actin ratio in experimental chemically induced liver fibrosis. Vestnik VolgGMU. 2014;3(51):55−58. (In Russ.) - Ellinidi VN, Kuzmina NS, Simonova IE, et al. Novye vozmozhnosti primeneniya α-SMA-biomarkera rannei stadii fidroza pri khronicheskom endometrite u bol’nykh endo-metriozom. Obstetrics and Gynaecology of St. Petersburg. 2018;(3–4):65−69. (In Russ.) - Hinz B. Myofibroblasts. Exp Eye Res. 2016;142:56–70. doi: 10.1016/j.exer.2015.07.009 - Adamyan LV, Aznaurova YaB. Molecular aspects of endometriosis. Problemy Reproduktsii. 2015;21(2):66-77. (In Russ.). doi: 10.17116/repro201521266-77 - Choi HJ, Park MJ, Kim BS, et al. Transforming growth factor β1 enhances adhesion of endometrial cells to mesothelium by regulating integrin expression. BMB Rep. 2017;50(8):429–434. doi: 10.5483/bmbrep.2017.50.8.097 - Florova MS. The role of growth factors in the pathogenesis of endometriosis. Journal of Obstetrics and Women’s Diseases. 2019;68(3):71–80. doi: 10.17816/JOWD68371-80

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisendometrioma

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (18)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK